Last reviewed · How we verify
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
0 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| NSAID's | NSAID's | marketed | Non-steroidal anti-inflammatory drug (NSAID) | Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) | Pain management, Inflammation, Rheumatology |
Therapeutic area mix
- Pain management, Inflammation, Rheumatology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Ain Shams University · 1 shared drug class
- IBSA Institut Biochimique SA · 1 shared drug class
- Insel Gruppe AG, University Hospital Bern · 1 shared drug class
- Pfizer · 1 shared drug class
- Rabin Medical Center · 1 shared drug class
- Shijiazhuang Yiling Pharmaceutical Co. Ltd · 1 shared drug class
- Takeda · 1 shared drug class
- Thomas Jefferson University · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Saglik Bilimleri Universitesi Gulhane Tip Fakultesi:
- Saglik Bilimleri Universitesi Gulhane Tip Fakultesi pipeline updates — RSS
- Saglik Bilimleri Universitesi Gulhane Tip Fakultesi pipeline updates — Atom
- Saglik Bilimleri Universitesi Gulhane Tip Fakultesi pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Saglik Bilimleri Universitesi Gulhane Tip Fakultesi — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/saglik-bilimleri-universitesi-gulhane-tip-fakultesi. Accessed 2026-05-16.